Tag: healthcare access Page 1 of 2

Trans Prisoners and Forced Detransition

On March 12, 2026

A transgender woman incarcerated in a federal prison sits alone in her cell, reflecting the growing controversy over policies that could force transgender inmates off hormone therapy under Executive Order 14168. (Image generated by ChatGPT using DALL·E, 2026.)

Executive Order 14168, issued on January 20, 2025 and titled Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government, has reshaped how transgender people are treated by federal institutions. While much public discussion has centered on gender markers or legal recognition of transgender identity, one of the most immediate and dangerous consequences of the order has emerged inside the federal prison system. In particular, policy changes following the order have led to attempts by federal prison authorities to discontinue hormone therapy and other gender-affirming medical treatments for incarcerated transgender people. For many transgender inmates, this policy shift represents not only a denial of identity but also a serious threat to physical and psychological health. At the same time, the logic behind these policies raises broader concerns about how transgender people may be treated by federal institutions beyond the prison system.

The executive order directs federal agencies to recognize only two sexes—male and female—defined as immutable and determined at conception (The White House, 2025). This directive eliminates gender identity as a category recognized in federal administration. When applied to the federal prison system, the policy affects how prisoners are classified, housed, and treated medically. Most critically, it has been used to justify attempts to eliminate or restrict gender-affirming healthcare for incarcerated transgender people.

Gender-affirming hormone therapy is widely recognized by major medical organizations as a necessary treatment for individuals diagnosed with gender dysphoria. Medical consensus holds that hormone therapy can significantly reduce psychological distress, depression, and suicide risk among transgender patients. Within prison environments—where individuals already face isolation, stress, and restricted autonomy—continuity of medical care is considered especially important. Nevertheless, following the issuance of Executive Order 14168, federal prison officials moved to halt or restrict such treatment.

Reporting by the Associated Press indicates that the policy shift prompted the Federal Bureau of Prisons to attempt to terminate or suspend hormone therapy for transgender inmates in federal custody (Riccardi & Kunzelman, 2025). The decision sparked immediate legal challenges from incarcerated transgender individuals who argued that the abrupt withdrawal of medically prescribed treatment would cause severe harm. In multiple cases, courts were asked to intervene to prevent the termination of hormone therapy.

In June 2025, a federal judge ruled that the Bureau of Prisons must continue providing hormone therapy to transgender inmates while litigation proceeds. Reuters journalist Nate Raymond reported that the court found the government had failed to justify abruptly ending treatment that physicians had previously deemed medically necessary (Raymond, 2025). The ruling emphasized that forcing transgender prisoners to discontinue hormone therapy could produce serious psychological consequences and potentially violate constitutional protections against cruel and unusual punishment.

Despite these court rulings, recent reporting suggests that federal prison policies continue to move toward restricting gender-affirming care. In March 2026, Samantha Riedel reported in Them that federal prison authorities had begun implementing policies requiring transgender inmates receiving hormone therapy to gradually discontinue those medications (Riedel, 2026). According to medical experts cited in the report, forced withdrawal from hormone therapy can lead to severe depression, anxiety, and increased risk of self-harm. For individuals who have relied on hormone therapy for years as part of a medically supervised transition, being forced off treatment can trigger profound physical and psychological distress.

These medical risks are particularly concerning in correctional environments. Prison systems already struggle with high rates of mental health crises, and incarcerated individuals frequently have limited access to specialized medical care. When transgender inmates are forced off hormone therapy, the resulting psychological distress can be intensified by the conditions of confinement, including isolation, stigma, and lack of support networks. The loss of hormone therapy can also have visible physical effects that may expose transgender prisoners to additional harassment or violence from other inmates.

Although these developments are occurring within federal prisons, the implications extend beyond incarcerated populations. Policies implemented within prisons often reflect broader ideological frameworks that can shape how government agencies treat marginalized groups more generally. When federal policy defines sex as immutable and rejects the legitimacy of gender identity, that definition may influence how transgender people are treated across a wide range of institutions, including healthcare systems, identification programs, and federal employment policies.

The attempt to eliminate hormone therapy for transgender prisoners demonstrates how quickly policy can shift from symbolic definitions to control over medical care and bodily autonomy. If federal institutions can deny gender-affirming treatment to incarcerated individuals based on a policy redefining sex, similar arguments could potentially be used to justify restrictions in other contexts. While prisoners occupy a uniquely vulnerable position under government authority, policies affecting them can serve as testing grounds for broader administrative approaches.

History offers numerous examples in which policies applied first to prisoners or other marginalized groups later expand into wider legal frameworks. In the case of Executive Order 14168, the removal of gender identity from federal policy raises concerns that transgender people may face increasing barriers to medical care and legal recognition across multiple institutions. For transgender Americans, the developments within federal prisons therefore represent more than a correctional policy dispute; they signal how federal authority may increasingly regulate transgender bodies and identities.

The ongoing legal challenges surrounding hormone therapy in federal prisons will play a significant role in determining the future of transgender healthcare within federal institutions. Courts must decide whether the abrupt withdrawal of medically necessary treatment constitutes deliberate indifference to serious medical needs, which could violate the Eighth Amendment’s prohibition on cruel and unusual punishment. The outcome of these cases will shape not only the lives of transgender prisoners but also the broader legal landscape governing transgender rights in the United States.

Executive Order 14168 has therefore created a situation in which the treatment of transgender inmates has become a focal point in a larger struggle over recognition, medical care, and bodily autonomy. The attempt to force transgender prisoners off hormone therapy illustrates how administrative policy decisions can translate into immediate and profound consequences for vulnerable individuals. At the same time, it raises deeper questions about how far such policies might extend and what they could mean for transgender people beyond prison walls.

References

Raymond, N. (2025, June 3). U.S. judge says federal prisons must continue hormone therapy for transgender inmates. Reuters. https://www.reuters.com/legal/us-judge-orders-prisons-continue-hormone-therapy-transgender-inmates

Riccardi, N., & Kunzelman, M. (2025, January 23). What to know about President Donald Trump’s order targeting transgender rights. Associated Press. https://apnews.com/article/trump-transgender-passports-prisons-eggs-sperm-da1d1d280658a8c85c57cfec2f30cefb

Riedel, S. (2026, March 10). Federal prisons are beginning to force trans inmates off hormone therapy. Them. https://www.them.us/story/federal-prisons-are-beginning-to-force-trans-inmates-off-hormone-therapy

The White House. (2025). Executive Order 14168: Defending women from gender ideology extremism and restoring biological truth to the federal government. https://public-inspection.federalregister.gov/2025-02090.pdf

Disappointed in Senator Durbin

By Katherine Walter

On November 11, 2025

In Dick Durbin

U.S. Sen. Dick Durbin speaks during the Illinois Democratic County Chairs’ Association brunch on Aug. 13, 2025, in Springfield, Illinois. (Dominic Di Palermo/Chicago Tribune/Tribune News Service via Getty Images)

When I was in college, I volunteered on the campaign of Dick Durbin for his first run for the U.S. Senate seat for Illinois. I remember knocking on doors and speaking to voters about his vision for fairness, compassion, and opportunity. Over the decades since then, I’ve admired his consistency, integrity, and leadership. From his advocacy for civil rights and consumer protections to his steadfast defense of democracy, Senator Durbin has been a voice I have long trusted.

That’s why his recent decision to side with Republicans on a measure to end the federal government shutdown deeply troubles me. According to multiple reports, in November 2025, Senator Durbin joined seven other Democrats in voting to advance a Republican-led continuing resolution intended to reopen the government (Sfondeles, 2025; Grisales & Garrett, 2025). While the bill provided temporary funding and back pay for federal workers, it failed to extend the enhanced Affordable Care Act (ACA) premium tax credits—a lifeline that has helped millions of Americans maintain access to health insurance since 2021 (Associated Press, 2025).

The expiration of these enhanced ACA tax credits could cause premiums to skyrocket, pushing millions off their insurance plans and destabilizing the individual health insurance market (Associated Press, 2025). For years, Democrats have fought to expand and secure these subsidies precisely because they save lives. Abandoning that effort, even temporarily, risks the health and well-being of ordinary families who cannot absorb the cost of rising premiums.

Senator Durbin defended his vote by calling the legislation “imperfect” but “necessary” to alleviate the growing strain on federal workers and agencies during the prolonged shutdown (Grisales & Garrett, 2025). Yet to me, this decision reflects a dangerous form of pragmatism—one that accepts short-term political relief at the expense of long-term justice.

Even more alarming is the fact that this measure arose from Republican efforts to hold the Supplemental Nutrition Assistance Program (SNAP) hostage in budget negotiations (Potter et al., 2025). Forcing millions of Americans to face hunger in order to extract political concessions is beyond comprehension and morally unacceptable. It reveals the degree to which the GOP is willing to use the most vulnerable members of society as bargaining chips—a tactic that, if not strongly resisted, will surely be used again in the future.

The move sets a disturbing precedent: if political leverage can be gained by threatening to withhold food and healthcare from those in need, what moral boundary remains? Senator Durbin, as the second-ranking Democrat in the Senate, had the power to send a message that such tactics would never be rewarded. Instead, his vote may embolden those who see cruelty as an effective negotiation strategy.

I do not write this out of anger, but out of heartbreak. I have admired Senator Durbin for much of my adult life. His record on immigration, education, and reproductive rights remains admirable. Yet in this moment, he seems to have forgotten that principles, not expedience, are what distinguish true leadership from mere management.

Ending the shutdown matters—but ending it on Republican terms and without protecting healthcare and nutrition assistance for millions sends the wrong message about what our values are worth. Illinois Democrats, including several prominent leaders, have voiced similar disappointment, warning that this compromise “is not a deal—it’s an empty promise” (Crisp, 2025).

As one of the people who once proudly campaigned for Senator Durbin’s first Senate victory, I hope he will remember that Illinoisans have long expected moral courage from him—not accommodation. The enhanced ACA tax credits must be renewed, and SNAP must be protected, not weaponized. The lives and dignity of millions of Americans depend on it.

References

Associated Press. (2025, November 10). An emerging shutdown deal doesn’t extend expiring health subsidies. AP News. https://apnews.com/article/2b5ae3651ff16783a00e00dc1ce264bf

Crisp, J. (2025, November 10). Illinois Democrats at odds with Durbin over vote to end shutdown. Daily Herald. https://www.dailyherald.com/20251110/us-congress-politics/illinois-democrats-at-odds-with-durbin-over-vote-to-end-shutdown/

Grisales, C., & Garrett, L. (2025, November 10). Senators, including Dick Durbin, take first step toward reopening the government after historic shutdown. WGLT (Illinois Public Radio). https://wglt.org/illinois/2025-11-10/senators-including-dick-durbin-take-first-step-toward-reopening-the-government-after-historic-shutdown

Potter, D., Franco, M. A., Peters, S., Wooten, T., Stimers, P., Roberson, J. E., & DeLacy, C. (2025, November 10). Senate advances funding bill to end record shutdown. Holland & Knight Alert. https://www.hklaw.com/en/insights/publications/2025/11/senate-advances-funding-bill-to-end-record-shutdown

Sfondeles, T. (2025, November 10). Sen. Dick Durbin facing backlash once again for joining GOP in measure to end government shutdown. Chicago Sun-Times. https://chicago.suntimes.com/us-senate/2025/11/10/sen-dick-durbin-compromise-measure-federal-government-shutdown-end-democrats-backlash

Sutherland, C. (2025, November 10). The eight senators who broke with Democrats to end the government shutdown. TIME. https://time.com/7332610/8-senators-broke-with-democrats-to-end-government-shutdown/

OPM Ends Gender-Affirming Care in 2026

By Katherine Walter

On August 25, 2025

In LGBTQ+ rights

The recent announcement from the Office of Personnel Management (OPM) that gender-affirming health care will be excluded from the Federal Employees Health Benefits (FEHB) and Postal Service Health Benefits (PSHB) programs beginning in 2026 represents a profound step backward in civil rights and health equity. Under this directive, chemical and surgical interventions for gender transition will no longer be covered, though counseling for gender dysphoria must remain available. Insurance carriers are required to develop exceptions processes for individuals currently undergoing such care, yet the parameters of those processes remain undefined. Providers of gender-affirming care are also barred from being listed in plan directories, effectively discouraging access (Office of Personnel Management, 2025; Moss, 2025).

To understand the gravity of this reversal, it is necessary to recall how hard-fought the gains for transgender health care under FEHB were. In 2014, OPM lifted the longstanding blanket exclusion of gender-affirming procedures, and by 2016 carriers were instructed not to categorically deny such care. This change aligned federal benefits with emerging medical consensus that gender-affirming treatments are not elective but medically necessary. The World Professional Association for Transgender Health (WPATH) and the Endocrine Society have long affirmed that access to hormone therapy and surgeries significantly reduces psychological distress, improves quality of life, and prevents serious health complications (Hembree et al., 2017; Coleman et al., 2022). For nearly a decade, transgender federal employees and retirees could rely on this coverage as a matter of equity and recognition of their humanity.

As a transgender woman who has been receiving gender-affirming health care for more than eleven years, this policy shift strikes me not just as a bureaucratic adjustment but as a direct threat to my life and well-being. Having undergone an orchiectomy, I rely on estradiol not simply as an affirming treatment, but as essential hormone replacement. Without it, my bones, cardiovascular health, cognition, and emotional stability would be at severe risk. Estradiol for me is no different than thyroid medication for someone with hypothyroidism—it is medically necessary, lifelong care. To see it lumped under a politically charged category of “optional” transition services is both scientifically inaccurate and deeply insulting.

What unsettles me most is the uncertainty this policy creates. OPM’s promise of an “exceptions process” offers little clarity. Will it protect those of us with medical histories spanning over a decade of consistent care? Or will it force us into endless appeals and denials, treating every prescription refill as a battle? This ambiguity is destabilizing, and I cannot help but feel that it is intentional—designed to make care harder to access and to discourage providers from stepping forward.

As a federal retiree, I gave years of service under the assumption that the benefits I earned would protect me equitably. Now, I feel as though my identity has made me a target within the very system I trusted. The estimated 14,000 transgender federal employees and retirees who will be affected are not faceless statistics; we are people who dedicated our careers to serving this country, only to be told that our health care needs are unworthy of recognition (Lambda Legal, 2025; them.us, 2025). The exclusion also signals a dangerous precedent: that essential medical care can be stripped away not because of evidence or cost, but because of politics.

This change must be understood in its broader social context. Over the past decade, transgender Americans have seen both progress and backlash. The Affordable Care Act’s Section 1557 extended nondiscrimination protections in health care, and the Supreme Court’s ruling in Bostock v. Clayton County (2020) affirmed that gender identity is protected under Title VII. Yet, simultaneously, states across the country have passed laws restricting access to gender-affirming care, particularly for youth, framing these measures as cultural wedge issues. The OPM directive extends that wave of exclusion into the federal system, embedding discrimination into the nation’s largest employer-based insurance program.

For me personally, this is not an abstract policy debate. It is about whether I will be able to continue accessing the medication that keeps me healthy and alive. It is about whether the years of progress we celebrated were only temporary reprieves. And it is about what message this sends to younger transgender people entering federal service today: that their health and dignity can be used as bargaining chips in political battles.

I cannot help but feel anxious about what the future holds, but I also feel resolved. This rollback will not go unchallenged. Advocacy groups such as Lambda Legal, the National Center for Transgender Equality, and others have already condemned it as unlawful and are preparing legal strategies (Lambda Legal, 2025). As a transgender woman and a retiree, I plan to add my voice to that chorus, because silence is what allows discrimination to endure. We have fought too hard, and for too long, to let the ground be taken out from under us without resistance.

References

Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., … Winter, S. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(sup1), S1–S259. https://doi.org/10.1080/26895269.2022.2100644

Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., … T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. https://doi.org/10.1210/jc.2017-01658

Lambda Legal. (2025, August 19). Lambda Legal condemns Trump administration’s illegal exclusion of gender-affirming care from employee health benefits. Retrieved August 22, 2025, from https://lambdalegal.org/newsroom

Moss, K. (2025, August 20). Coverage for gender-affirming care will be eliminated from FEHB plans in 2026. Government Executive. Retrieved August 22, 2025, from https://www.govexec.com

Office of Personnel Management. (2025). Carrier Letter 2025-01b: Chemical and surgical sex-trait modification exclusion. Retrieved August 22, 2025, from https://opm.gov

them.us. (2025, August 20). Trump Admin to end coverage of gender-affirming care for federal workers. them. Retrieved August 22, 2025, from https://www.them

The Criminalization of Transgender Identity

By Katherine Walter

On March 6, 2025

In LGBTQ+ rights

In recent years, a troubling trend has emerged across the United States: the introduction and enactment of laws that effectively criminalize aspects of being transgender. These laws go beyond limiting access to medical care or restricting participation in public life; they represent a broader effort to marginalize and erase transgender individuals.

While Illinois has upheld legal protections for transgender individuals, the national wave of anti-trans legislation is deeply concerning. These laws do not only harm those living in conservative states but also create ripple effects that extend nationwide, even reaching those in progressive areas. The increasing criminalization of transgender identity threatens fundamental civil rights, healthcare access, and the ability of transgender people to live openly and safely.

State legislatures across the country have introduced and, in some cases, passed extreme laws targeting transgender identity and gender-affirming care. Some states have proposed criminalizing transgender people for identifying as a gender different from what was assigned at birth, labeling this as fraud and imposing severe legal penalties. Others have removed gender identity from anti-discrimination protections, allowing increased discrimination against transgender individuals in employment, housing, and public services. Laws have also been passed that restrict or even ban access to gender-affirming medical care, not only for minors but in some cases for adults as well.

At the federal level, executive orders and policy changes have further undermined transgender rights. Government efforts to redefine gender strictly based on biological sex have effectively stripped transgender individuals of legal recognition in various federally funded programs. Funding for gender-affirming healthcare has also been targeted, making it more difficult for transgender individuals to access essential medical services, even in states that support such care. These measures reinforce discrimination at a national level and create a legal environment where transgender people are increasingly marginalized.

For those living in states like Illinois, where transgender rights are legally protected, it may seem as though these laws will not have an impact. However, the reality is far more complex. Federal policies can override state protections, particularly when it comes to funding for healthcare programs. Clinics that provide gender-affirming care may struggle to maintain services if federal funding is restricted. Additionally, the growing number of transgender individuals fleeing hostile states in search of healthcare and safety could place a strain on resources in states that offer protection.

Beyond the legal and healthcare implications, the rise of anti-trans legislation contributes to a culture of hostility and discrimination. Even in states with protective laws, the national conversation around transgender rights affects public attitudes, often leading to increased discrimination, workplace bias, and violence against transgender people. Hate crimes targeting transgender individuals have been on the rise, fueled by rhetoric that paints them as threats rather than human beings deserving of dignity and respect. Traveling becomes riskier for transgender people, as neighboring states with restrictive laws create environments where something as simple as using a public restroom or presenting as one’s authentic self could lead to harassment, arrest, or violence.

As a transgender woman living in Illinois, the inconsistency of protections across different states creates a constant sense of uncertainty. Rights that are protected in one place can disappear the moment state lines are crossed. The ability to live freely and without fear should not be dependent on geography, yet that is the reality that many transgender people face. Even in a progressive state, the fear of national policy changes and the emboldening of anti-trans sentiment weighs heavily on daily life.

The economic and social consequences of these laws extend beyond the transgender community. Businesses are pulling events and operations from states that pass extreme anti-trans laws, leading to financial losses. Universities in these states are seeing declines in applications from LGBTQ+ students, affecting campus diversity. If the spread of these laws continues, even states that have supported transgender rights may face political pressure to conform to restrictive national policies.

At its core, the push to criminalize transgender identity is a moral and ethical crisis. These laws deny transgender people their dignity, autonomy, and basic human rights. The argument that such laws are meant to protect children or uphold traditional values is nothing more than a justification for discrimination. Medical professionals overwhelmingly agree that gender-affirming care is essential and life-saving. The refusal to recognize transgender identities and the restriction of medical care only lead to higher rates of depression, anxiety, and suicide among transgender individuals. These laws are not about protecting anyone—they are about controlling and erasing a marginalized group.

The continued expansion of anti-trans laws should concern everyone, not just those directly affected. When governments begin rolling back rights for one group, history has shown that other marginalized communities will soon be targeted. Today, transgender people face the brunt of these attacks, but tomorrow, it could be anyone whose identity or autonomy does not align with the political agenda of those in power. If these laws are allowed to stand, they will embolden further government overreach into personal identity, medical autonomy, and individual freedoms.

Addressing this crisis requires action. Elections matter, and voting for candidates who support transgender rights is crucial at every level of government. Legal challenges to these laws are ongoing, and organizations fighting for transgender rights need support. Social advocacy is also critical—challenging anti-trans rhetoric, educating others, and standing up for transgender individuals in everyday life all contribute to pushing back against this wave of discrimination. Protecting the most vulnerable members of the transgender community is essential, whether through direct financial support, providing safe spaces, or amplifying their voices.

The criminalization of transgender identity is not about safety or protecting society—it is about control. The ability to live as one’s authentic self should never be a political debate. No one should have to fear losing their rights, their healthcare, or their safety simply for existing. This fight is about human dignity, and it is one that cannot be ignored.